Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.

Autor: Olav Dalgard, Ola Weiland, Geir Noraberg, Lars Karlsen, Lars Heggelund, Martti Färkkilâ, Ulla Balslev, Erika Belard, Anne Øvrehus, Mette Skalshøi Kjær, Henrik Krarup, Birgit Thorup Røge, Sofie Hallager, Lone G Madsen, Alex Lund Laursen, Martin Lagging, Nina Weis

Publikováno v: PLoS ONE, Vol 12, Iss 7, p e0179764 (2017)

Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of HCV genotype 3 infecti

Externí odkaz: https://doaj.org/article/c96e7f90a1224916ae10a8afbc4b5c77

Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011

Autor: Erika Belard, Henriette Ytting, Tine Jess, Mark A. Ainsworth, Jakob Ørskov Sørensen, Ole Haagen Nielsen, Mikael Andersson

Publikováno v: Liver International. 38:532-541

Background and Aims Inflammatory bowel disease (IBD) may be complicated by primary sclerosing cholangitis (PSC). We aimed to assess the characteristics of Danish PSC-IBD patients and to compare their prognosis with IBD patients without PSC. Methods A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f1f64424de1013fa037677341ccbdf6
https://doi.org/10.1111/liv.13548

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections - a Scandinavian real-life study

Autor: Erika Belard, Lone Galmstrup Madsen, Mette S Kjær, Geir Noraberg, Ola Weiland, Nina Weis, Henrik Krarup, Alex Lund Laursen, Lars Normann Karlsen, Ulla Balslev, Olav Dalgard, Anne Øvrehus, Sofie Hallager, Martin Lagging, Lars Heggelund, Martti Färkkilâ, Birgit Røge

Publikováno v: Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections : A Scandinavian real-life study ', PLOS ONE, vol. 12, no. 7, e0179764 . https://doi.org/10.1371/journal.pone.0179764
PLoS ONE, Vol 12, Iss 7, p e0179764 (2017)
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study ', PloS one, vol. 12, no. 7, e0179764 . https://doi.org/10.1371/journal.pone.0179764
Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Heggelund, L, Färkkilâ, M, Balslev, U, Belard, E, Øvrehus, A, Skalshøi Kjær, M, Krarup, H, Thorup Røge, B, Hallager, S, Madsen, L G, Lund Laursen, A, Lagging, M & Weis, N 2017, ' Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study ', P L o S One, vol. 12, no. 7, pp. e0179764 . https://doi.org/10.1371/journal.pone.0179764
PLoS ONE

BACKGROUND AND AIMS: Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34309f14de034eaa686df7c02d7cf19
https://hdl.handle.net/10642/7274

The Effect of Sofosbuvir Containing Regimes in Patients with HCV Genotype 3 Infection-A Scandinavian Real-Life Experience

Autor: M. Färkkilâ, Ola Weiland, Anne Øvrehus, Lone Galmstrup Madsen, Noel S. Weiss, Lars Normann Karlsen, Martin Lagging, Mette S Kjær, Erika Belard, Geir Noraberg, Henrik Krarup, Olav Dalgard, Lars Heggelund, Sofie Hallager, Ulla Balslev, B. T. Roege, N.M. Weiss

Publikováno v: Dalgard, O, Weiland, O, Noraberg, G, Karlsen, L, Lagging, M, Heggelund, L, Färkkilâ, M, Weiss, N S, Balslev, U, Belard, E, Øvrehus, A L H, Kjaer, M S, Krarup, H, Roege, B T, Hallager, S, Madsen, L & Weiss, N M 2016, ' The Effect of Sofosbuvir Containing Regimes in Patients with HCV Genotype 3 Infection-A Scandinavian Real-Life Experience ', Journal of Hepatology, vol. 64, no. 2, SAT-228, pp. S803 . https://doi.org/10.1016/S0168-8278(16)01568-3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df667aab049cab2586f109caa26bed2
https://vbn.aau.dk/da/publications/96efeef5-3754-4876-a49a-be6356c97163

Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection

Autor: Bolette Søborg, Anne Marie Werlinrud, Pernille Ravn, Erika Belard, Inge Nordgaard-Lassen, Synne Semb, Annette Brylov, Henrik S. Thomsen, Morten Ruhwald, Merete Lund Hetland, Frank Krieger Jensen

Publikováno v: Inflammatory bowel diseases. 17(11)

Background: During screening for latent tuberculosis infection (LTBI), before anti-tumor-necrosis-factor-α treatment, most patients are already receiving immunosuppressive therapy. The objective was to evaluate the performance of the QuantiFERON Gol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1444898ac809086755362d042d7cbd43
https://pubmed.ncbi.nlm.nih.gov/21319275